Harbin Medisan Pharmaceutical Co., Ltd. announced at the EGM held on November 25, 2022 that the company approved election of Zhuge Guomin, Liang Yanfei and Zhu Zihong as non-independent directors, Liu Hongquan as independent director and Zhai Yuping and Gao Lu as non-employee supervisors.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
8.49 CNY | -1.16% |
|
+0.12% | -37.80% |
1st Jan change | Capi. | |
---|---|---|
-37.80% | 366M | |
+55.35% | 848B | |
+31.64% | 627B | |
-0.10% | 363B | |
+15.47% | 318B | |
+13.10% | 299B | |
+15.51% | 243B | |
+16.72% | 225B | |
+16.54% | 179B | |
+4.31% | 167B |
- Stock Market
- Equities
- 002900 Stock
- News Harbin Medisan Pharmaceutical Co., Ltd.
- Harbin Medisan Pharmaceutical Co., Ltd. Approves Management Appointments